Literature DB >> 19917882

Endothelial progenitor cells bind and inhibit platelet function and thrombus formation.

Haissam Abou-Saleh1, Daniel Yacoub, Jean-François Théorêt, Marc-Antoine Gillis, Paul-Eduard Neagoe, Benoit Labarthe, Pierre Théroux, Martin G Sirois, Maryam Tabrizian, Eric Thorin, Yahye Merhi.   

Abstract

BACKGROUND: Interactions of endothelial progenitor cells (EPCs) with vascular and blood cells contribute to vascular homeostasis. Although platelets promote the homing of EPCs to sites of vascular injury and their differentiation into endothelial cells, the functional consequences of such interactions on platelets remain unknown. Herein, we addressed the interactions between EPCs and platelets and their impact on platelet function and thrombus formation. METHODS AND
RESULTS: Cultured on fibronectin in conditioned media, human peripheral blood mononuclear cells differentiated, within 10 days of culture, into EPCs, which uptake acetylated low-density lipoprotein, bind ulex-lectin, lack monocyte/leukocyte markers (CD14, P-selectin glycoprotein ligand-1, L-selectin), express progenitor/endothelial markers (CD34, vascular endothelial growth factor receptor-2, von Willebrand factor, and vascular endothelial cadherin), and proliferate in culture. These EPCs bound activated platelets via CD62P and inhibited its translocation, glycoprotein IIb/IIIa activation, aggregation, and adhesion to collagen, mainly via prostacyclin secretion. Indeed, this was associated with upregulation of cyclooxygenase-2 and inducible nitric oxide synthase. However, the effects on platelets in vitro were reversed by cyclooxygenase and cyclooxygenase-2 inhibition but not by nitric oxide or inducible nitric oxide synthase inhibition. Moreover, in a ferric chloride-induced murine arterial thrombosis model, injection of EPCs led to their incorporation into sites of injury and impaired thrombus formation, leading to an incomplete occlusion with 50% residual flow.
CONCLUSIONS: Peripheral blood mononuclear cell-derived EPCs bind platelets via CD62P and inhibit platelet activation, aggregation, adhesion to collagen, and thrombus formation, predominantly via upregulation of cyclooxygenase-2 and secretion of prostacyclin. These findings add new insights into the biology of EPCs and define their potential roles in regulating platelet function and thrombosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19917882      PMCID: PMC3694872          DOI: 10.1161/CIRCULATIONAHA.109.894642

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  37 in total

1.  Recombinant P-selectin glycoprotein-ligand-1 delays thrombin-induced platelet aggregation: a new role for P-selectin in early aggregation.

Authors:  Jean-François Théorêt; Wissam Chahrour; Daniel Yacoub; Yahye Merhi
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

Review 2.  Platelets in inflammation and atherogenesis.

Authors:  Meinrad Gawaz; Harald Langer; Andreas E May
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 3.  Peripheral blood as a source of stem cells for regenerative medicine.

Authors:  Paola Romagnani; Laura Lasagni; Sergio Romagnani
Journal:  Expert Opin Biol Ther       Date:  2006-03       Impact factor: 4.388

4.  Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro.

Authors:  Harald Langer; Andreas Eberhard May; Karin Daub; Ulrich Heinzmann; Peter Lang; Michael Schumm; Dietmar Vestweber; Steffen Massberg; Tanja Schönberger; Iris Pfisterer; Antonis K Hatzopoulos; Meinrad Gawaz
Journal:  Circ Res       Date:  2005-12-22       Impact factor: 17.367

5.  Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype.

Authors:  H C de Boer; C Verseyden; L H Ulfman; J J Zwaginga; I Bot; E A Biessen; T J Rabelink; A J van Zonneveld
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-20       Impact factor: 8.311

6.  Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals.

Authors:  Mervin C Yoder; Laura E Mead; Daniel Prater; Theresa R Krier; Karim N Mroueh; Fang Li; Rachel Krasich; Constance J Temm; Josef T Prchal; David A Ingram
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

7.  Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix.

Authors:  Eli I Lev; Zeev Estrov; Khatira Aboulfatova; David Harris; Juan F Granada; Carlos Alviar; Neal S Kleiman; Jing-fei Dong
Journal:  Thromb Haemost       Date:  2006-10       Impact factor: 5.249

8.  Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells.

Authors:  Karin Daub; Harald Langer; Peter Seizer; Konstantinos Stellos; Andreas E May; Pankaj Goyal; Boris Bigalke; Tanja Schönberger; Tobias Geisler; Dorothea Siegel-Axel; Robert A J Oostendorp; Stephan Lindemann; Meinrad Gawaz
Journal:  FASEB J       Date:  2006-10-31       Impact factor: 5.191

9.  Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo.

Authors:  Steffen Massberg; Ildiko Konrad; Katrin Schürzinger; Michael Lorenz; Simon Schneider; Dietlind Zohlnhoefer; Katharina Hoppe; Matthias Schiemann; Elisabeth Kennerknecht; Susanne Sauer; Christian Schulz; Sandra Kerstan; Martina Rudelius; Stefan Seidl; Falko Sorge; Harald Langer; Mario Peluso; Pankaj Goyal; Dietmar Vestweber; Nikla R Emambokus; Dirk H Busch; Jon Frampton; Meinrad Gawaz
Journal:  J Exp Med       Date:  2006-04-17       Impact factor: 14.307

Review 10.  Clinical and therapeutical implications of EPC biology in atherosclerosis.

Authors:  N Werner; G Nickenig
Journal:  J Cell Mol Med       Date:  2006 Apr-Jun       Impact factor: 5.310

View more
  22 in total

1.  Interactions between endothelial progenitor cells (EPC) and titanium implant surfaces.

Authors:  Thomas Ziebart; Anne Schnell; Christian Walter; Peer W Kämmerer; Andreas Pabst; Karl M Lehmann; Johanna Ziebart; Marc O Klein; Bilal Al-Nawas
Journal:  Clin Oral Investig       Date:  2012-03-10       Impact factor: 3.573

2.  Patient-derived endothelial progenitor cells improve vascular graft patency in a rodent model.

Authors:  J D Stroncek; L C Ren; B Klitzman; W M Reichert
Journal:  Acta Biomater       Date:  2011-09-06       Impact factor: 8.947

Review 3.  Nanotechnology in cell replacement therapies for type 1 diabetes.

Authors:  Alexander U Ernst; Daniel T Bowers; Long-Hai Wang; Kaavian Shariati; Mitchell D Plesser; Natalie K Brown; Tigran Mehrabyan; Minglin Ma
Journal:  Adv Drug Deliv Rev       Date:  2019-02-02       Impact factor: 15.470

4.  Red blood cell distribution width and 3-year outcome in patients undergoing cardiac catheterization.

Authors:  Yaron Arbel; Edo Y Birati; Ariel Finkelstein; Amir Halkin; Shlomo Berliner; Ben-Zion Katz; Miri Revivo; Hila Saranga; Itzhak Herz; Gad Keren; Shmuel Banai
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

Review 5.  Endothelial progenitor cells: therapeutic perspective for ischemic stroke.

Authors:  Yu-Hui Zhao; Bin Yuan; Ji Chen; De-Hui Feng; Bin Zhao; Chao Qin; Yan-Fang Chen
Journal:  CNS Neurosci Ther       Date:  2012-12-11       Impact factor: 5.243

6.  Enhanced endothelialization of a new stent polymer through surface enhancement and incorporation of growth factor-delivering microparticles.

Authors:  Hao Xu; Kytai T Nguyen; Emmanouil S Brilakis; Jian Yang; Eric Fuh; Subhash Banerjee
Journal:  J Cardiovasc Transl Res       Date:  2012-05-26       Impact factor: 4.132

Review 7.  Targeting stem cell niches and trafficking for cardiovascular therapy.

Authors:  Nicolle Kränkel; Gaia Spinetti; Silvia Amadesi; Paolo Madeddu
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

8.  In vitro functional testing of endothelial progenitor cells that overexpress thrombomodulin.

Authors:  John D Stroncek; Yujing Xue; Nabila Haque; Jeffrey H Lawson; William M Reichert
Journal:  Tissue Eng Part A       Date:  2011-05-25       Impact factor: 3.845

9.  Human umbilical cord blood-derived endothelial cells reendothelialize vein grafts and prevent thrombosis.

Authors:  Melissa A Brown; Lisheng Zhang; Vrad W Levering; Jiao-Hui Wu; Lisa L Satterwhite; Leigh Brian; Neil J Freedman; George A Truskey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-26       Impact factor: 8.311

10.  Circulating endothelial progenitor cell and platelet microparticle impact on platelet activation in hypertension associated with hypercholesterolemia.

Authors:  Nicoleta Alexandru; Doina Popov; Emanuel Dragan; Eugen Andrei; Adriana Georgescu
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.